: +1 (646) 661-6066-
$2,000 Read More Diabetic Peripheral Neuropathy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2016’, provides an overview of the Diabetic Peripheral Neuropathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diabetic Peripheral Neuropathy, complete wit... -
$2,000 Read More Mumps – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Mumps - Pipeline Review, H1 2016’, provides an overview of the Mumps pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mumps, complete with analysis by stage of development, drug target, mechanism of action (MoA),... -
$2,000 Read More Elephantiasis (Lymphatic Filariasis) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2016’, provides an overview of the Elephantiasis (Lymphatic Filariasis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Elephantiasis (Lymphatic Filaria... -
$2,000 Read More Streptococcus pyogenes Infections – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Streptococcus pyogenes Infections - Pipeline Review, H1 2016’, provides an overview of the Streptococcus pyogenes Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Streptococcus pyogenes Infections, com... -
$2,000 Read More Botulism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Botulism - Pipeline Review, H1 2016’, provides an overview of the Botulism pipeline landscape. The report provides comprehensive information on the therapeutics under development for Botulism, complete with analysis by stage of development, drug target, mechanism of acti... -
$2,000 Read More H3N2 Infection – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for H3N2 Infection, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological a... -
$2,000 Read More Allergic Asthma – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Allergic Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological ... -
$2,000 Read More Metastatic Renal Cell Carcinoma – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Metastatic Renal Cell Carcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive ... -
$2,000 Read More Atopic Dermatitis – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Atopic dermatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacologica... -
$2,000 Read More Traumatic Brain Injury – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Traumatic brain injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacol...
Sorry, there is no ad related to this category!
-
$4,995 Read More Hepatitis B Therapeutics in Major Developed Markets to 2021 – Increasing N...
Hepatitis B is an infectious liver disease caused by the Hepatitis B Virus (HBV) and […]
-
$2,000 Read More Spinal Muscular Atrophy (SMA) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) – Pipeline Review, H1 2016’, provides an overview […]
-
$2,500 Read More Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Obstructive Pulmonary Disease. […]
-
$2,000 Read More Prader-Willi Syndrome (PWS) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Prader-Willi Syndrome (PWS) – Pipeline Review, H1 2016’, provides an overview of […]
-
$4,995 Read More Asthma Therapeutics in Asia-Pacific Markets to 2021 – High Prevalence and ...
Asthma is a common chronic inflammatory disease of the airways, characterized by recurrent attacks of […]
-
$6,995 Read More Frontier Pharma: Ovarian Cancer – Identifying and Commercializing First-in...
Ovarian cancer is the sixth most common cancer in females and it also has the […]
-
$2,000 Read More Ventilator Associated Pneumonia (VAP) – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Ventilator Associated Pneumonia (VAP) – Pipeline Review, H1 2016’, provides an overview […]
-
$2,500 Read More Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Leishmaniasis (Kala-Azar). Report […]
-
$2,000 Read More Cholera – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Cholera – Pipeline Review, H1 2016’, provides an overview of the Cholera […]
-
$2,000 Read More Open-Angle Glaucoma – Pipeline Review, H1 2016
The report provides comprehensive information on the therapeutics under development for Open-Angle Glaucoma, complete with […]
